Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NARATRIPTAN vs SUMATRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NARATRIPTAN vs SUMATRIPTAN: Safety Overview

Metric NARATRIPTAN SUMATRIPTAN
Total FAERS Reports 526 17,442
Deaths Reported 9 305
Death Rate 1.7% 1.7%
Hospitalizations 102 1,580
Average Patient Age 49.2 yrs 45.7 yrs
% Female Patients 90.0% 84.9%
FDA Approval Date Apr 22, 2011 Apr 14, 2014
Manufacturer Hikma Pharmaceuticals USA Inc. Sun Pharmaceutical Industries, Inc.
Route ORAL ORAL
Marketing Status Discontinued Discontinued